Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GIMap_Carnitine_Benzinidizole_Treatment_SamllIntestine_SeptNov2019_PositivePolarity

ABSTRACT: Treatment of mice after being infected with C2C12 with carnitine and benzinidizole involving small intestine only.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mice

SUBMITTER: Laura-Isobel McCall

PROVIDER: MSV000084297 | MassIVE |

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Similar Datasets

C2C12_Treatment_with_Carnitine_ddMS2_QExactivePlus_Positive-Polarity_Polar_C18

Project description:ddMS2 data of C2C12 treated with Carnitine, untreated C2C12, water and carnitine in water using polar C18 column in Q Exactive Plus

2018-11-06 | MSV000083111 | MassIVE

Metabolomics Workbench ST000332 - GNPS - Effects of Giardia intestinalis on mice GI tract

Project description:This experiment aimed to see the effects of Giardia Intestinalis on the small intestine of mice. The metabolites of the proximal and distal ends of the small intestine of healthy mice were compared to those of mice who had been infected with Giardia intestinalis for 7 days.

2018-08-02 | MSV000082697 | GNPS

GNPS-acute stage Chagas disease carnitine treatment, large intestine (negative mode)

Project description:Large intestine samples from mice infected with 50,000 Trypanosoma cruzi parasites or left uninfected. One week post-infection, mice were treated with carnitine, benznidazole or vehicle. Animals were euthanized after 10 days of treatment and organs collected. Metabolites were extracted with 50% methanol followed by 3:1 dichloromethane-methanol and analyzed by C8 chromatography, with negative mode ddMS2 data collection (data-dependent).

2020-03-24 | MSV000085143 | GNPS

GNPS-acute stage Chagas disease carnitine treatment, large intestine (positive mode)

Project description:Large intestine samples from mice infected with 50,000 Trypanosoma cruzi parasites or left uninfected. One week post-infection, mice were treated with carnitine, benznidazole or vehicle. Animals were euthanized after 10 days of treatment and organs collected. Metabolites were extracted with 50% methanol followed by 3:1 dichloromethane-methanol and analyzed by C8 chromatography, with positive mode ddMS2 data collection (data-dependent).

2020-03-24 | MSV000085142 | GNPS

RNA-seq of mouse small intestine samples from different treatment groups

Project description:The aim of this project was to explore the role of Alginate oligosaccharides (AOS) on the development small intestine. The mice were treated with one dose busulfan then the mice were dosed with AOS for 5 weeks. Then the small intestine were collected. The RNA from small intestine was used for the RNA-seq analysis to search the role of AOS on small intestine development. Groups: W5A0 was from AOS 0 treatment; W5A10 was from AOS 10 treatment; W5BA0 was from busulfan and AOS 0 treatment; W5BA10 was from busulfan and AOS 10 treatment.

2020-09-30 | GSE137989 | GEO

RNA-sequencing data of intestinal tissue of mice administered proanthocyanidins (PAC) and infected with Heligomosomoides polygyrus (Hp)

Project description:We show here the transcriptional response in the small intestine of mice infected with Hp with or without concurrent PAC administration

2022-01-01 | GSE174756 | GEO

GImap_negative_C8_7.5mint_chaoyi

Project description:apply C8 column and 7.5 minutes run to feces, small intestine and large intestine samples from mice under negative polarity mode in ddMS2.

2019-04-03 | MSV000083661 | MassIVE

Effects of Giardia intestinalis on mice GI tract

2015-02-23 | ST000332 | MetabolomicsWorkbench

Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine

Project description:Current therapies for Cancer of the Small Intestine provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Cancer of the Small Intestine. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Cancer of the Small Intestine.

| 2003040 | ecrin-mdr-crc

Proteome of L-carnitine-grown Eubacterium limosum ATCC 8486

Project description:Eubacterium limosum ATCC 8486 makes acetate and butyrate from various substrates and is found in the human intestine. The proteome of L-carnitine-grown Eubacterium limosum was obtained in order to identify enzymes required for growth on L-carnitine, in particular to identify components that are unique to growth on L-carnitine in comparison to other substrates for acetogenesis, such as lactic acid. L-carnitine and derviatives are converted to trimethylamine (TMA) by certain members of the gut microbiome, metabolism of TMA is now tied to progression of cardiovascular disease. Demethylation of carnitine is observed during growth of Eubacterium limosum on this substrate, and does not produce TMA. Carnitine demethylation by organisms like Eubacterium limosum could lessen TMA production in the gut, thereby lessening the propensity towards atherorsclerosis caused by metabolism of TMA in the body. The carnitine proteome led to the description of a carnitine:tetrahydrofolate methyltransferase system. The key carnitine demethylating enzyme is a member of the widespread TMA methyltransferase protein superfamily.

2020-06-19 | PXD013961 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data